{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:44:06Z","timestamp":1774529046166,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","patient-research.elsevier.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.contraception.2014.06.002","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T14:32:55Z","timestamp":1402583575000},"page":"535-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial"],"prefix":"10.1016","volume":"90","author":[{"given":"Unnop","family":"Jaisamrarn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somsak","family":"Chaovisitsaree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surasak","family":"Angsuwathana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osot","family":"Nerapusee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2014.06.002_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archfami.9.2.179","article-title":"New treatments and therapeutic strategies for acne","volume":"9","author":"Thiboutot","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.contraception.2014.06.002_bb0010","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2004.01.023","article-title":"An update on the pathogenesis and management of acne vulgaris","volume":"51","author":"Harper","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.contraception.2014.06.002_bb0015","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.1016\/S0010-7824(98)00080-8","article-title":"Effectiveness of oral contraceptives in the treatment of acne","volume":"58","author":"Redmond","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.06.002_bb0020","first-page":"69","article-title":"Examining the use of oral contraceptives in the management of acne","volume":"2","author":"Salvaggio","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.contraception.2014.06.002_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","article-title":"Classification and pharmacology of progestins","volume":"61","author":"Schindler","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2014.06.002_bb0030","first-page":"121","article-title":"The phasic approach to oral contraception: the triphasic concept and its clinical application","volume":"28","author":"Upton","year":"1983","journal-title":"Int J Fertil"},{"issue":"Suppl. 156","key":"10.1016\/j.contraception.2014.06.002_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00016349209156509","article-title":"Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive","volume":"71","author":"London","year":"1992","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.contraception.2014.06.002_bb0080","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/S0002-9378(94)05019-2","article-title":"Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate","volume":"170","author":"Corson","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.06.002_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0010-7824(90)90039-X","article-title":"Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins","volume":"41","author":"Phillips","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.06.002_bb0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.06.002_bb0065","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.contraception.2014.06.002_bb0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0010-7824(88)90104-7","article-title":"Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives","volume":"38","author":"Kloosterboer","year":"1988","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.06.002_bb0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000182537","article-title":"Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel","volume":"38","author":"Jung-Hoffmann","year":"1992","journal-title":"Horm Res"},{"key":"10.1016\/j.contraception.2014.06.002_bb7580","first-page":"283","article-title":"Acne treatment with a new estroprogestinic biphasic combination containing desogestrel","volume":"22","author":"Falsetti","year":"1991","journal-title":"Acta Eur Fertil"},{"key":"10.1016\/j.contraception.2014.06.002_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09546639809160698","article-title":"The Leeds revised acne grading system","volume":"9","author":"O'Brien","year":"1998","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.contraception.2014.06.002_bb0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/ejc.6.1.46.53","article-title":"Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate","volume":"6","author":"Vartiainen","year":"2001","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2014.06.002_bb0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/13625180500252638","article-title":"The effect of a phasic oral contraceptive containing desogestrel on seborrhea and acne","volume":"11","author":"Kr\u00e4nzlin","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2014.06.002_bb0100","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/09513590802454943","article-title":"Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3mg and ethynilestradiol 30 microg and chlormadinone 2mg on skin and hormonal hyperandrogenic manifestations","volume":"24","author":"Lello","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2014.06.002_bb0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.contraception.2010.01.011","article-title":"Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02mg ethinylestradiol and 2mg chlormadinone acetate administered in a 24\/4-day regimen","volume":"81","author":"Brucker","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.06.002_bb9005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2009.02.016","article-title":"Efficacy of an oral contraceptive containing EE 0.03mg and CMA 2mg (Belara\u00ae) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial","volume":"80","author":"Plewig","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.06.002_bb0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414003023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414003023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T12:26:43Z","timestamp":1538569603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782414003023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0010782414003023"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.06.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}